Skip to main content
SpringerLink
Log in
Book cover

Medikamentös induzierte neurologische und psychiatrische Störungen pp 73–116Cite as

Bewusstseinstrübungen

  • Chapter

  • 795 Accesses

This is a preview of subscription content, log in via an institution.

eBook
USD   19.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abbruzzese G (2002) The medical management of spasticity. Eur J Neurol 9(Suppl 1): 30–34

    PubMed  Google Scholar 

  • Adelsberg BR (1997) Sedation and performance issues in the treatment of allergic conditions. 1997 Arch Intern Med 157: 494–500

    CAS  Google Scholar 

  • Auzepy P, Boukara N, Richard C, Giudicelli JF (1983) Acute poisoning caused by beta blockers in the adult. Apropos of 7 cases. Ann Cardiol Angiol (Paris) 32: 253–258

    CAS  Google Scholar 

  • Bansinath M, Shukla VK, Tumdorf H (1995) Propofol modulates the effects of chemoconvulsants acting at GABAergic, glycinergic and glutamate receptor subtypes. Anaesthesiology 83: 809–815

    CAS  Google Scholar 

  • Bares M, Kanovsky P, Rektor I (2003) Excessive daytime sleepiness and ’sleep attacks’ induced by entacapone. Fundam Clin Pharmacol 17: 113–116

    Article  PubMed  CAS  Google Scholar 

  • Bauer J, Schwalen S (2000) Topiramat. Pharmakologische Charakteristik und Stellenwert in der aktuellen Epilepsietherapie. Nervenarzt 71: 495–501

    Article  PubMed  CAS  Google Scholar 

  • Benkert O, Hippius H (2003) Kompendium der psychiatrischen Pharmakotherapie, 4. Aufl. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Berridge MJ, Downes CP, Hanley MR (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59: 411–419

    Article  PubMed  CAS  Google Scholar 

  • Betts T, Waegemans T, Crawford P et al. (2000) A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 9: 80–87

    PubMed  CAS  Google Scholar 

  • Bever KA, Perry PJ (1998) Olanzapine: A serotonin-dopamine-receptor antagonist for antipsychotic therapy. Am J Health-Syst Pharm 55: 1003–1016

    PubMed  CAS  Google Scholar 

  • Beyenburg S, Bauer J, Elger CE (2000) Therapie des generalisierten tonisch-klonischen Status epilepticus im Erwachsenenalter. Nervenarzt 71: 65–77

    Article  PubMed  CAS  Google Scholar 

  • Bischoff P, Schmidt GN, Scharein E, Bromm B, Schulte am Esch J (2004) Clonidine induced sedation and analgesia. An EEG study. J Neurol 251: 219–221

    Article  PubMed  CAS  Google Scholar 

  • Bittermann H-J, Steinhoff BJ (1997) Topiramat — ein wirksames neues Antiepileptikum. Eine offene prospektive Studie. Nervenarzt 68: 836–838

    Article  PubMed  CAS  Google Scholar 

  • Block F (2001) Gabapentin zur Schmerztherapie. Schmerz 15: 280–288

    Article  PubMed  CAS  Google Scholar 

  • Bousquet J (1998) Antihistamines in severe/chronic rhinitis. Clin Exp Allergy 28(Suppl 6): 49–53

    PubMed  CAS  Google Scholar 

  • Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vagero M, Svensson K (2005) A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for manic bipolar disorder. J Clin Psychiat 66: 111–121

    Article  CAS  Google Scholar 

  • Bridle C, Palmer S, Bagnall A-M, Darba J, Duffy S, Sculpher M, Riemsma R (2004) A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Health Technology Assessment 8: 9–63

    Google Scholar 

  • Broocks A, Junghanns K, Thiel A, Gleiter CH, Bandelow B (2000) Neue Antidepressiva im Vergleich zu klassischen Trizyklika. Wirkmechanismen und klinische Beurteilung. Fortschr Neurol Psychiat 68: 17–24

    PubMed  CAS  Google Scholar 

  • Busch H, Frings A (1998) Pharmacotherapy of alcohol-withdrawal syndrome in hospitalised patients. Clinical and methodological aspects. Pharmacopsychiatry 2: 232–237

    Google Scholar 

  • Carroll MF, Burge MR, Schade DS (2003) Severe hypoglycaemia in adults. Rev Endocrinol Metabol Dis 4: 149–157

    Google Scholar 

  • Cipriani A, Barbui C, Geddes JR (2005) Suicide, depression and antidepressants. BMJ 330: 373–374

    PubMed  Google Scholar 

  • Chou R, Peterson K, Helfand M (2004) Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: A systematic review. J Pain Sympt Manag 28: 140–175

    CAS  Google Scholar 

  • Clark AJ, Ahmedzai SH, Allan LG, Camacho F, Horbay GLA, Richarz U, Simpson K (2004) Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin 20: 1419–1428

    Article  PubMed  CAS  Google Scholar 

  • Clemens A, Riemann JF, Siegel EG (2003) Optimierte Diabetestherapie beim Typ-2-Diabe-tiker. Med Klin 98: 484–492

    Google Scholar 

  • Conner CS, Watanabe AS (1979) Clonidine overdose: A review. Am J Hosp Pharm 36:906–911

    PubMed  CAS  Google Scholar 

  • Croonenberghs J, Fegert JM, Findling RL, de Smedt G, van Dongen S and the Risperidone Disruptive Behavior Study Group (2005) Risperidone in children with disruptive behavior disorders and subaverage intelligence: A 1-year, open-label study of 504 patients. J Am Acad Child Adolesc Psychiat 44: 64–72

    Google Scholar 

  • Dario A, Tomei G (2004) A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf 27: 799–818

    PubMed  CAS  Google Scholar 

  • DCCT — The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependant diabetes mellitus. N Engl J Med 329: 977–986

    Google Scholar 

  • DeArmond B, Francisco CA, Lin JS, Huang FY, Halladay S, Bartziek RD, Skare KL (1995) Safety-profile of over-the-counter naproxen sodium. Clin Ther 17: 587–601

    Article  PubMed  CAS  Google Scholar 

  • Delgado Escueta AV, Wasterlain C, Treiman DM, Porter RJ (1982) Current concepts in neurology: management of status epilepticus. N Engl J Med 306: 1337–1440

    Article  PubMed  CAS  Google Scholar 

  • Devinsky O, Leppik I, Willmore L, Pellock J, Dean C, Gates J, Ramsay R (1995) Safety of intravenous valproate. Ann Neurol 38: 670–674

    Article  PubMed  CAS  Google Scholar 

  • Dunner DL (2000) Optimizing lithium treatment. J Clin Psychiatry 61(Suppl 9): 76–81

    PubMed  CAS  Google Scholar 

  • Easley RB, Altemeier WA (2000) Central nervous system manifestations of an ibuprofen overdose reversed by naloxone. Pediatr Emerg Care 16: 39–41

    Article  PubMed  CAS  Google Scholar 

  • Edwards JE, McQuay HJ, Moore RA, Collins SL (1999) Reporting of adverse effects in clinical trials should be improved: Lessons from acute postoperative pain. J Pain Sympt Manag 18: 427–436

    CAS  Google Scholar 

  • El-Armouche A, Zolk O, Eschenhagen T (2003) Citalopram. Dtsch Med Wochenschr 128: 2253–2256

    PubMed  CAS  Google Scholar 

  • Endmann M, Kutz R (2005) Kindliche, akzidentelle Baclofen-Intoxikation mit Koma, Bradykardie und passagerer Sehstörung. Klein Pädiatr 217: 89–91

    CAS  Google Scholar 

  • Estelle F, Simons R (1999) H1-receptor antagonists: safety issues. Ann Allergy Asthma Immunol 83: 481–488

    PubMed  CAS  Google Scholar 

  • Estler C-J (1992) Pharmakologie und Toxikologie, 3. Aufl. Schattauer, Stuttgart

    Google Scholar 

  • Etminan M, Samii A, Takkouche B, Rochon PA (2001) Increased risk of somnolence with new dopaminergic agents in patients with Parkinson’s disease: A meta-analysis of randomized controlled trials. Drug Saf 24: 863–868

    PubMed  CAS  Google Scholar 

  • Farrell M, Heinrichs M, Tilelli JA (1991) Response of life threatening dimenhydrinate intoxication to sodium bicarbonate administration. J Toxicol Clin Toxicol 29: 527–535

    PubMed  CAS  Google Scholar 

  • Feldman W, Shanon A, Leiken L, Ham-pong A, Peterson R (1992) Central nervous system side-effects of antihistamines in schoolchildren. Rhinol Suppl 13:13–19

    CAS  Google Scholar 

  • Feirrera JJ, Galitzky M, Rascol O (2000) Sleep attacks and Parkinson’s disease treatment. Lancet 355: 1333–1334

    Google Scholar 

  • Fischer RS, Sachdeo RC, Pellock J, Penovich PE, Magnus L, Bernstein P (2001) Rapid initiation of gabapentin. A randomized, controlled trial. Neurology 56: 743–748

    Google Scholar 

  • French JA, Kanner AM, Bautista J et al. (2004) Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy. Neurology 62: 1261–1273

    PubMed  CAS  Google Scholar 

  • Frey R, Schreinzer D, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S (2002) Letale Intoxikationen mit Antidepressiva und Neuroleptika. Nervenarzt 73: 629–636

    Article  PubMed  CAS  Google Scholar 

  • Freye E, Levy JV (2004) Einsatz der Opioide beim alten Patienten — Pharmakokinetische und pharmakodynamische Überlegungen. Anasthesiol Intensivmed Notfall 39: 527–537

    CAS  Google Scholar 

  • Friedel HA, Fitton A (1993) Flupirtine. A review of its pharmacological properties and therapeutic efficacy in pain states. Drugs 45: 548–569

    PubMed  CAS  Google Scholar 

  • Gareri P, Gravina T, Ferreri G, De Sarro G (1999) Treatment of epilepsy in the elderly. Prog Neurobiol 58: 389–407

    Article  PubMed  CAS  Google Scholar 

  • Garcia-Booreguero D, Schwarz C, Larossa O, de la Llave Y, Garcia de Yébenes J (2003) L-Dopa-induced excessive daytime sleepiness in PD. A placebo-controlled case with MSLT assessment. Neurology 61: 1008–1010

    Google Scholar 

  • Gelber DA, Good DC, Dromerick A, Sergay S, Richardson M (2001) Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke. Stroke 32: 1841–1846

    PubMed  CAS  Google Scholar 

  • Hamann A, Morcos M, Nawroth P (2004) Orale Diabetestherapie. Welche Substanz ist wann indiziert? Internist 45: 1356–1363

    Article  PubMed  CAS  Google Scholar 

  • Haria M, Fitton A, Peters DH (1994) Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 48: 617–637

    PubMed  CAS  Google Scholar 

  • Hegerl U, Möller HJ (2000) Pharmakotherapie der Altersdepression. Nervenarzt 71: 1–8

    Article  PubMed  CAS  Google Scholar 

  • Hill SJ, Ganellin CR, Timmermann H, Schwartz JC, Shankley NP, Young JM et al. (1997) International Union of Pharmacology XIII. Classification of histamine receptors. Pharmacol Rev 49: 253–278

    PubMed  CAS  Google Scholar 

  • Hermann WM, Kern U, Aigner M (1987) On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an ongoing twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis. Postgrad Med J 63(Suppl 3): 87–103

    Google Scholar 

  • Hirschfeld RMA, Keck PE, Kramer M, Karcher K, Canuso C, Eerdekens M, Grossman F (2004) Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiat 161: 1057–1065

    PubMed  Google Scholar 

  • Hobson DE, Lang AE, Wayne Martin WR, Razmy A, Rivest J, Fleming J (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. JAMA 287:455–463

    Article  PubMed  Google Scholar 

  • Hogl B, Seppi K, Brandauer E, Glatzl S, Frauscher B, Niedermuller D, Wenning G, Poewe W (2003) Increased daytime sleepiness in Parkinson’s disease: a questionaire survey. Mov Disord 18: 319–323

    PubMed  Google Scholar 

  • Holstein A, Plaschke A, Egberts EH (2001) Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metabol Res Rev 17: 467–473

    CAS  Google Scholar 

  • Huber B (2002) Effekte von Topiramat bei Patienten mit Epilepsie und intellektueller Beeinträchtigung. Nervenarzt 73: 525–532

    Article  PubMed  CAS  Google Scholar 

  • Jackson JE, Bressler R (1981) Clinical pharmacology in sulphonylurea hypoglycaemic agents. Drugs 22(3): 221–245

    Google Scholar 

  • Jenkinson ML, Fitzpatrick R, Streete PJ, Volans GN (1988) The relationship between plasma ibuprofen concentrations and toxicity in acute ibuprofen overdose. Hum Toxicol 7(4): 319–324

    PubMed  CAS  Google Scholar 

  • Jost W (2005) Therapie des idiopathischen Parkinson-Syndroms, 3. Aufl. Unimed, Bremen

    Google Scholar 

  • Kahl GF (1997) Vergiftungen. In: Scholz H, Schwabe U (Hrsg) Taschenbuch der Arzneibehandlung, 11. Aufl. Gustav Fischer, Stuttgart

    Google Scholar 

  • Kalso E, Edwards JE, Moore RA, McOuay HJ (2004) Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 112: 373–380

    Article  CAS  Google Scholar 

  • Kappagoda C, Schell DN, Hanson RM, Hutchins P (1998) Clonidine overdose in childhood: implications of increased prescribing. J Paediatr Child Health 34: 508–512

    Article  PubMed  CAS  Google Scholar 

  • Kasper S (1997) Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine. J Clin Psychopharmacol 17: 19–28

    Article  Google Scholar 

  • Klein-Schwartz W (2002) Trends and toxic effects from pediatric clonidine exposures. Arch Pediatr Med 156: 392–396

    Google Scholar 

  • Kolodzik JM, Eilers MA, Angelos MG (1990) Nonsteroidal anti-inflammatory drugs and coma: A case report of fenprofen overdose. Ann Emerg Med 19: 378–381

    PubMed  CAS  Google Scholar 

  • Kopf A, Janson W, Stein C (2003) Anwendungsmöglichkeiten für Opioide bei chronischem Nichttumorschmerz. Anaesthesist 52: 103–114

    Article  PubMed  CAS  Google Scholar 

  • Krämer G (2000) Oxcarbazepin: Ein neues Antiepileptikum zur Mono-und Kombinationstherapie. Akt Neurol 27: 59–71

    Google Scholar 

  • Krieger S, Petros S, Berroushot J, Krieger D (1999) Enzephalopathien bei erworbenen metabolischen Erkrankungen. In: Schwab S, Krieger D, Müllges W, Hamann G, Hacke W (Hrsg) Neurologische Intensivmedizin. Springer, Berlin Heidelberg New York Tokio, S 609–646

    Google Scholar 

  • Lam AM, Parkin JA (1981) Cimetidine and prolonged post-operative somnolence. Can Anaesth Soc J 28: 450–452

    Article  PubMed  CAS  Google Scholar 

  • LaRoche SM, Helmers SL (2004) The new antiepileptic drugs. Scientific review. JAMA 291: 605–614

    PubMed  CAS  Google Scholar 

  • Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA (2004) Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ 329: 75–79

    PubMed  Google Scholar 

  • Levenson JL (1985) Neuroleptic malignant syndrome. Am J Psychiat 142: 1137–1142

    PubMed  CAS  Google Scholar 

  • Levine ML (1978) Cimetidine-induced coma in cirrhosis of the liver. JAMA 240: 1238

    PubMed  CAS  Google Scholar 

  • Lobmann R, Lehnert H (2003) Hypoglykämie. Internist 44: 1275–1281

    Article  PubMed  CAS  Google Scholar 

  • Lofton AL, Klein-Schwartz W (2004) Evaluation of lamotrigine toxicity reported to poison centers. Ann Pharmacother 38: 1811–1815

    PubMed  CAS  Google Scholar 

  • Love JN (1994) Beta blocker toxicity after overdose: when do symptoms develop? J Emerg Med 12: 799–802

    Article  PubMed  CAS  Google Scholar 

  • Lowenstein DH, Alldredge BK (1998) Status epilepticus. N Engl J Med 338: 970–976

    Article  PubMed  CAS  Google Scholar 

  • Mach M-A von, Weilemann LS (2002) Zunehmende Bedeutung von Antidepressiva bei suizidalen und parasuizidalen Intoxikationen. Dtsch Med Wochenschr 127: 2053–2056

    Google Scholar 

  • Maier B (1998) Analgesie und Sedierung. Durchbrechen des Circulus vitiosus von Schmerz und Angst. Notfall-und Rettungsmedizin 1: 49–63

    Google Scholar 

  • Mann RD, Pearce GL, Dunn N, Shakir S (2000) Sedation with “non-sedating” antihista-mines: four prescription-event monitoring studies in general practice. BMJ 320: 1184–1186

    Article  PubMed  CAS  Google Scholar 

  • Marinangeli F, Ciccozzi A, Donatelli F, Di Pietro A, Iovinelli G, Paladini A, Varrassi G (2002) Clonidine for treatment of postoperative pain: a dose-finding study. Eur J Pain 6:35–42

    Article  PubMed  CAS  Google Scholar 

  • McConville BJ, Sorter MT (2004) Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychosis. J Clin Psychiatry 65(Suppl 6): 20–29

    PubMed  CAS  Google Scholar 

  • McQuay H (1999) Opioids in pain management. Lancet 353: 2229–2232

    Article  PubMed  CAS  Google Scholar 

  • McMahon FG, Arndt WF Jr, Newton JJ, Montgomery PA, Perhach JL (1987) Clinical experience with flupirtine in the US. Postgrad Med J 63(Suppl 3): 81–85

    PubMed  Google Scholar 

  • Minto CF, Schnider TW, Shafer SL (1997) Pharmacokinetics and Pharmacodynamics of remifentanyl. Il-Model application. Anaesthesiology 86: 24–33

    CAS  Google Scholar 

  • Möller JC, Stiasny K, Cassel W, Peter JH, Krüger HP, Oertel WH (2000) „Schlafattacken“ bei Parkinson-Patienten. Eine Nebenwirkung von Nonergolin-Dopaminagonisten oder ein Klasseneffekt von Dopaminergika? Nervenarzt 71: 670–676

    PubMed  Google Scholar 

  • Montané E, Vallano A, Laporte JR (2004) Oral antispastic drugs in nonprogressive neurologic diseases. A systematic review. Neurology 63: 1357–1363

    PubMed  Google Scholar 

  • Moscati RM, Moore GP (1990) Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Ann Emerg Med 19: 12–15

    PubMed  CAS  Google Scholar 

  • Nicholson AN (1985) Central effects of H1 and H2 antihistamines. Aviat Space Environ Med 56: 293–298

    PubMed  CAS  Google Scholar 

  • Nieber K (2004) Carbamazepin. Dtsch Med Wochenschr 129: 627–629

    Article  PubMed  CAS  Google Scholar 

  • Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J (2001) Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 14: 540–545

    Google Scholar 

  • Ostermann ME, Young B, Sibbald WJ, Nicolle MW (2000) Coma mimicking brain death following baclofen overdose. Int Care Med 26: 1144–1146

    CAS  Google Scholar 

  • O’suilleabhain PE, Dewey RB (2002) Contributions of dopaminergic drugs and disease severity of daytime sleepiness in Parkinson disease. Arch Neurol 59: 986–989

    PubMed  Google Scholar 

  • Pajonk F-G, Fleiter B (2003) Psychopharmakotherapie im Notarztdienst. Anaesthesist 52: 577–585

    Article  PubMed  CAS  Google Scholar 

  • Pal S, Bhattacharya KF, Agapito C, Chaudhuri KR (2001) A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson’s disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Trans 108: 71–77

    Article  CAS  Google Scholar 

  • Parkinson Study Group (2004) Pramipexole vs. Levodopa as initial treatment for Parkinson disease. Arch Neurol 61: 1044–1053

    Article  Google Scholar 

  • Passalacqua G, Scordamaglia A, Ruffoni S, Parodi MN, Canonica GW (1993) Sedation from H1 antagonists: evaluation methods and experimental results. Allergol Immunopathol (Madr) 21: 79–83

    CAS  Google Scholar 

  • Payne TA, Bleck TP (1997) Status epilepticus. Critical Care Clinics 13: 17–39

    Article  PubMed  CAS  Google Scholar 

  • Perry HE, Wright RO, Shannon MW, Woolf AD (1998) Baclofen overdose: Drug experimentation in a group of adolescents. Pediatr 101: 1045–1048

    CAS  Google Scholar 

  • Plank J, Bock G-M (2003) Medikamentöse Behandlung des Typ 2 Diabetes. Wien Med Wochenschr 21/22: 452–458

    Google Scholar 

  • Pirker W, Happe S (2000) Sleep attacks in Parkinson’s disease. Lancet 356: 597–598

    Article  PubMed  CAS  Google Scholar 

  • Preskorn SH (1993) Pharmakokinetics of antidepressants: Why and how they are relevant to treatment. J Clin Psychiat 54(Suppl): 14–34

    Google Scholar 

  • Priest RG, Gimbrett R, Roberts M, Steinert J (1995) Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders. Acta Psychiat Scand 386(suppl): 40–43

    CAS  Google Scholar 

  • Rascol O, Brooks DJ, Korzyn AD, De Deyn PP, Clarke CE, Lang AE (2000) A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. N Engl J Med 342: 1484–1491

    Article  PubMed  CAS  Google Scholar 

  • Razmy A, Lang AE, Shapiro CM (2004) Predictors of impaired daytime sleep and wakefulness in patients with Parkinson’s disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 61: 97–102

    Article  PubMed  Google Scholar 

  • Reider N, Zloczower M, Fritsch P, Kofler H (1998) Antihistaminika (Teil I). Hautarzt 49: 674–681

    PubMed  CAS  Google Scholar 

  • Reis DJ (1996) Neurons and receptors in the rostroventrolateral medulla mediating the antihypertensive actions of drugs acting at imidazole receptors. J Cardiovasc Pharmacol 27(Suppl 3): 11–18

    Google Scholar 

  • Reith DM, Dawson AH, Epid D, Whyte IM, Buckley NA, Sayer GP (1996) Relative toxicity of beta blockers in overdose. J Toxicol Clin Toxicol 34: 273–278

    Article  PubMed  CAS  Google Scholar 

  • Richelson E (1996) Synaptic effects of antidepressants. J Clin Psychopharmacol 1S–7S

    Google Scholar 

  • Riechelmann H (2005) Orale Antihistaminika der 2. Generation bei allergischer Rhinitis. Laryngo-Rhino-Otol 84: 30–41

    CAS  Google Scholar 

  • Ringe JD, Miethe D, Pittrow D, Wegscheider K (2003) Analgetic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysis. Arzneimittelforschung 53: 496–502

    PubMed  CAS  Google Scholar 

  • Rosen F von (2004) Akute Intoxikationen. In: Brandt T, Dichgans J, Diener HC (Hrsg) Therapie und Verlauf neurologischer Erkrankungen, 4. Aufl. Kohlhammer, Stuttgart

    Google Scholar 

  • Roth T, Rye DB, Borchert LD, Bartlett C, Bliwise DL, Cantor C, God JM, Hubble JP, Musch B, Olanow CW, Pollak C, Stern MB, Watts R (2003) Assessment of sleepiness und unintended sleep in Parkinson’s disease patients taking dopamine agonists. Sleep Med 4: 275–280

    PubMed  Google Scholar 

  • Royal M, Wienecke G, Mowa V, Ward S, Bhakta B, Jensen M, Gunyea I (2001) Retrospective study of efficacy of tizanidine in the treatment of chronic pain. Pain Med 2: 249

    Google Scholar 

  • Rupprecht R, Baghai TC, Möller H-J (2004) Neuentwicklungen in der Pharmakotherapie der Depression. Nervenarzt 75: 273–280

    PubMed  CAS  Google Scholar 

  • Salpeter S, Greyber E, Pasternak G, Salpeter E (2003) Risc of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev CD002967

    Google Scholar 

  • Sanderson PM, Eltringham R (1998) The role of clonidine in anaesthesia. Hosp Med 59: 221–223

    PubMed  CAS  Google Scholar 

  • Schachter M, Luszick J, Jager B, Verboom C, Sohlke E (1998) Safety and tolerability of moxonidine in the treatment of hypertension. Drug Saf 19: 191–203

    PubMed  CAS  Google Scholar 

  • Schäfer I, Lambert M, Naber D (2004) Atypische Antipsychotika bei therapieresistenter Schizophrenic. Nervenarzt 75: 79–91

    PubMed  Google Scholar 

  • Schaffrath E, Kuhlen R, Tonner MPH (2004) Analgesie und Sedierung in der Intensivmedizin. Anaesthesist 11: 1111–1130

    Google Scholar 

  • Schmidt D, Elger CE (2004) Worin unterscheidet sich Oxcarbazepin von Carbamazepin? Nervenarzt 75: 153–160

    Article  PubMed  CAS  Google Scholar 

  • Schwarz S, Schwab S, Hacke W (1999) Status epilepticus. Rationelle Diagnostik und aktuelle Therapiekonzepte. Anaesthesist 48: 455–466

    PubMed  CAS  Google Scholar 

  • Scholz H, Schwabe U (Hrsg, 1997) Taschenbuch der Arzneibehandlung, 11. Aufl 1997. Gustav Fischer, Stuttgart

    Google Scholar 

  • Schwabe U (1997) Stoffwechselkrankheiten. In: Scholz H, Schwabe U (Hrsg) Taschenbuch der Arzneimittelbehandlung, 11. Aufl. Gustav Fischer, Stuttgart, S 286–293

    Google Scholar 

  • Schug S, Merry A, Acland R (1991) Treatment principles for the use of opioids in pain of non-malignant origins. Drugs 42: 228–239

    PubMed  CAS  Google Scholar 

  • Schulze-Bonhage A, Feil B, Fauser S, Hömberg V (2004) Levetiracetam in der Kombinationsbehandlung fokaler Epilepsien. Nervenarzt 75: 749–754

    Article  PubMed  Google Scholar 

  • Scott JC, Stanski DR (1987) Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 240: 159–166

    PubMed  CAS  Google Scholar 

  • Seifert S, Bronstein AC, McGuire T (2000) Massive ibuprofen ingestion with survival. J Toxicol Clin Toxicol 38: 55–57

    Article  PubMed  CAS  Google Scholar 

  • Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F (2004) Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114: 634–641

    Article  Google Scholar 

  • Simons FER, Simons KJ (1994) Drug therapy: The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med 330: 1663–1670

    Article  PubMed  CAS  Google Scholar 

  • Sloan P, Slatkin N, Ahdieh H (2005) Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study. Support Care Cancer 13: 57–65

    Article  PubMed  Google Scholar 

  • Slugg PH, Haug MT, Pippenger CE (1992) Ranitidine pharmacokinetics and adverse central nervous system reactions. Arch Intern Med 152: 2325–2329

    Article  PubMed  CAS  Google Scholar 

  • Smolinske SC, Hall AH, Vandenberg SA, Spoerke DG, McBride PV (1990) Toxic effects of non steroidal anti-inflammatory drugs in overdose. An overview of recent evidence on clinical effects and dose-response relationships. Drug Saf 5: 252–274

    PubMed  CAS  Google Scholar 

  • Sonnenblick M, Rosin AJ, Weissberg N (1982) Neurological and psychiatric side effects of cimetidine — report of three cases and review of the literature. Postgrad Med J 58: 415–418

    Article  PubMed  CAS  Google Scholar 

  • Spiller HA, Klein-Schwartz W, Colvin JM, Villalobos D, Johnson PD, Anderson DL (2005) Toxic clonidine ingestion in children. J Pediatr 146: 263–266

    PubMed  Google Scholar 

  • Spiller HA, Bosse GM, Adamson LA (2004) Retrospective analysis of tizanidine (Zanaflex) overdose. J Toxicol Clin Toxicol 42: 593–596

    Article  PubMed  CAS  Google Scholar 

  • Stang M, Wysowski DK, Butler Jones D (1999) Incidence of lactic acidosis in metformin users. Diabetes Care 22: 925–927

    PubMed  CAS  Google Scholar 

  • Tan EK, Lum SY, Fook-Chong SMC, Teoh ML, Yih Y, Tan L, Tan A, Wong MC (2002) Evaluation of somnolence in Parkinson’s disease: Comparison with age-and sex-matched controls. Neurology 58: 465–468

    PubMed  CAS  Google Scholar 

  • Taubolet P, Chariou A, Berdeaux A et al. (1993) Pathophysiology and management of self-poisoning with beta blockers. J Toxicol Clin Toxicol 31: 531–551

    Google Scholar 

  • Ten Eick AP, Blumer JL, Reed MD (2001) Safety of antihistamines in children. 2001 Drug Saf 24: 119–147

    Google Scholar 

  • Thomsen K, Schou M (1999) Avoidance of lithium intoxication: advice based on knowledge about the renal lithium clearance under various circumstances. Pharmacopsychiatry 32: 83–86

    Article  PubMed  CAS  Google Scholar 

  • Tiecks FP, Einhaupl KM (1994) Treatment alternatives of alcohol withdrawal delirium. Nervenarzt 65: 213–219

    PubMed  CAS  Google Scholar 

  • Timmer RT, Sands JM (1999) Lithium intoxication. J Am Soc Nephrol 10: 666–674

    PubMed  CAS  Google Scholar 

  • Treiman DM (1989) Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia 30(Suppl 2): 4–10

    Google Scholar 

  • Treiman DM, Meyers PD, Walton NY et al. for the Veterans Affairs Status Epilepticus Study Group (1998) A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 339: 792–798

    Article  PubMed  CAS  Google Scholar 

  • Turnheim K (2004) Arzneimittelwechselwirkungen mit Antiepileptika. Wien Klin Wochenschr 116: 112–118

    Article  PubMed  CAS  Google Scholar 

  • UKPDS — UK Prospective Diabetes Study Group (1995) UK prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: A progressive disease. Diabetes 44: 1249–1258

    Google Scholar 

  • Vale JA, Meredith TJ (1986) Acute poisoning due to non-steroidal anti-inflammatory drugs. Clinical features and management. Med Toxicol 1: 12–31

    PubMed  CAS  Google Scholar 

  • Wagstaff AJ, Bryson HM (1997) Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs 53: 435–452

    PubMed  CAS  Google Scholar 

  • Wallin CJ, Hulting J (1983) Massive metoprolol poisoning treated with prenalterol. Acta Med Scand 214: 253–255

    PubMed  CAS  Google Scholar 

  • Walsh GM, Annunziato L, Frossard N, Knol K, Levander S, Nicolas JM, Taglialatela M, Tharp MD, Tillement JP, Timmerman H (2001) New insights into the second generation antihistamines. Drugs 61: 207–236

    PubMed  CAS  Google Scholar 

  • Wappler F, Scholz J, Prause A et al. (1998) Stufenkonzept zur Analgosedierung in der Intensivmedizin mit Sufentanyl. Anästhesiol Intensivmed Schmerzther 33: 18–26

    Google Scholar 

  • Wilby MJ, Hutchinson PJ (2004) The pharmacology of chlormethiazole: a potential neuroprotective agent? CNS Drug Rev 10: 281–294

    PubMed  CAS  Google Scholar 

  • Yatham LN, Paulsson B, Mullen J, Vagerö M (2004) Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 24: 599–606

    PubMed  CAS  Google Scholar 

  • Zafonte R, Lombard L, Elovic E (2004) Antispasticity medications. Uses and limitations of enteral therapy. Am J Phys Med Rehabil 83: 50–58

    Google Scholar 

  • Zimmerman JL (2003) Poisonings and overdoses in the intensive care unit: general and specific management issues. Crit Care Med 31: 2794–2801

    PubMed  Google Scholar 

  • Zuckerman GB, Uy CC (1995) Shock, metabolic acidosis and coma following ibuprofen overdose in a child. Ann Pharmacother 29: 869–871

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik, Klinikum Dortmund gGmbH, Beurhausstr. 40, 44137, Dortmund

    Dr. med. C. Spitzer

Authors
  1. Dr. med. C. Spitzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik, Helios-Kliniken Schwerin, Wismarsche Straße 392-397, 19049, Schwerin

    Frank Block

  2. Gangelter Einrichtungen Krankenhaus Maria Hilf, Fachkrankenhaus für Psychiatrie und Psychotherapie, Brunchstraße 6, 52538, Gangelt

    Christian Prüter

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Spitzer, C. (2006). Bewusstseinstrübungen. In: Block, F., Prüter, C. (eds) Medikamentös induzierte neurologische und psychiatrische Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28604-7_6

Download citation

  • DOI: https://doi.org/10.1007/3-540-28604-7_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28590-8

  • Online ISBN: 978-3-540-28604-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation